I wonder if INCY has patents specific to use of JAKs for alopecia and related disorders or if ACRS could stand to benefit on this front (even if actually behind in the clinic).
I suck at patents so if this is laughable let me know. But wouldn't they need something like orphan drug protection? How could they keep a marketed, patented drug from being used in another indication?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.